Stewart Christopher P. 4
4 · Bionano Genomics, Inc. · Filed Feb 17, 2023
Insider Transaction Report
Form 4
Stewart Christopher P.
Chief Financial Officer
Transactions
- Award
Common Stock
2023-02-15+105,000→ 231,373 total - Award
Stock Option (Right to Buy)
2023-02-15+490,000→ 490,000 totalExercise: $1.63Exp: 2033-02-14→ Common Stock (490,000 underlying)
Footnotes (3)
- [F1]Represents restricted stock unit award granted under the Issuer's 2018 Equity Incentive Plan.
- [F2]Includes 2,285 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan (the "ESPP") on June 10, 2022 and 2,509 shares acquired under the ESPP on December 10, 2022.
- [F3]The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of February 15, 2023 (the "Grant Date") such that the option shall be fully vested and exercisable on the four-year anniversary of the Grant Date.